Literature DB >> 3409450

Potentiation of cis-diamminedichloroplatinum nephrotoxicity by amikacin in rats.

H T Jongejan1, A P Provoost, J C Molenaar.   

Abstract

The nephrotoxic interaction between cis-diamminedichloroplatinum (CDDP) and amikacin (AMI) was studied in rats. Following a single dose of CDDP (5 mg/kg i.v.), AMI (60 mg/kg s.c.) was given for 14 days. When given alone CDDP caused a 40% fall in the glomerular filtration rate (GFR), whereas AMI alone had no effect on GFR. This nonnephrotoxic course of AMI potentiated the CDDP-induced fall in GFR. Only a limited recovery of renal function was observed during a 15-week follow-up period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409450     DOI: 10.1007/bf00257319

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration.

Authors:  D N Gilbert; D C Houghton; W M Bennett; C E Plamp; K Reger; G A Porter
Journal:  Proc Soc Exp Biol Med       Date:  1979-01

2.  The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients.

Authors:  A Haas; L Anderson; T Lad
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

3.  Cis-diamminedichlorplatinum-induced acute renal failure in the rat.

Authors:  S Chopra; J S Kaufman; T W Jones; W K Hong; M K Gehr; R J Hamburger; W Flamenbaum; B F Trump
Journal:  Kidney Int       Date:  1982-01       Impact factor: 10.612

4.  Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.

Authors:  C L Bregman; P D Williams
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Nephrotoxicity of aminoglycosides in young and adult rats.

Authors:  A P Provoost; O Adejuyigbe; E D Wolff
Journal:  Pediatr Res       Date:  1985-11       Impact factor: 3.756

6.  Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.

Authors:  J C Gonzalez-Vitale; D M Hayes; E Cvitkovic; S S Sternberg
Journal:  Cancer Treat Rep       Date:  1978-05

7.  Nephrotoxicity of cis-diamminedichloroplatinum (II) (cis-platinum) and the additive effect of antibiotics: morphological and functional observation in rats.

Authors:  J Kawamura; A Soeda; O Yoshida
Journal:  Toxicol Appl Pharmacol       Date:  1981-05       Impact factor: 4.219

8.  Nephrotoxicity of cis-platin comparing young and adult rats.

Authors:  H T Jongejan; A P Provoost; E D Wolff; J C Molenaar
Journal:  Pediatr Res       Date:  1986-01       Impact factor: 3.756

9.  Development of renal function in the rat. The measurement of GFR and ERPF and correlation to body and kidney weight.

Authors:  A P Provoost; M H de Keijzer; E D Wolff; J C Molenaar
Journal:  Ren Physiol       Date:  1983

10.  Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity.

Authors:  W C Elliott; D C Houghton; D N Gilbert; J Baines-Hunter; W M Bennett
Journal:  J Lab Clin Med       Date:  1982-10
View more
  1 in total

1.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.